Paul Wilson

A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.

D. Vaughn, R. Kuschner, N. Kanesa-thasan, 2007, Vaccine.

The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial

C. Gedye, D. Sheffield, R. Sullivan, 2020, Trials.

Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis

J. Neoptolemos, J. Neoptolemos, C. McKay, 2001, Gut.

Communicable Diseases Intelligence

E. Green, D. Durrheim, M. Kirk, 2023 .